193 related articles for article (PubMed ID: 24292759)
1. Acquired von Willebrand syndrome associated with Hashimoto's thyroiditis and subcutaneous mucosa-associated lymphoid tissue lymphoma.
Koyama T; Fujimoto K; Shima M
Intern Med; 2013; 52(23):2661-3. PubMed ID: 24292759
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of inhibitors in acquired von Willebrand syndrome.
Mohri H; Motomura S; Kanamori H; Matsuzaki M; Watanabe S; Maruta A; Kodama F; Okubo T
Blood; 1998 May; 91(10):3623-9. PubMed ID: 9572997
[TBL] [Abstract][Full Text] [Related]
3. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome.
Federici AB
Hum Immunol; 2005 Apr; 66(4):422-30. PubMed ID: 15866707
[TBL] [Abstract][Full Text] [Related]
4. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
[TBL] [Abstract][Full Text] [Related]
5. A two-step approach (Enzyme-linked immunosorbent assay and confirmation assay) to detect antibodies against von Willebrand factor in patients with Acquired von Willebrand Syndrome.
Franchi F; Biguzzi E; Stufano F; Siboni SM; Baronciani L; Peyvandi F
Thromb Res; 2014 Dec; 134(6):1316-22. PubMed ID: 25300810
[TBL] [Abstract][Full Text] [Related]
6. Acquired von Willebrand Syndrome in a Patient with Multiple Comorbidities, Including MALT Lymphoma with IgA Monoclonal Gammopathy and Hyperviscosity Syndrome.
Owari M; Harada-Shirado K; Togawa R; Fukatsu M; Sato Y; Fukuchi K; Endo M; Takahashi H; Kimura S; Osaki T; Souri M; Ichinose A; Shibata Y; Hashimoto Y; Ikezoe T
Intern Med; 2023 Feb; 62(4):605-611. PubMed ID: 35871597
[TBL] [Abstract][Full Text] [Related]
7. A new ELISA assay for diagnosis of acquired von Willebrand syndrome.
Siaka C; Rugeri L; Caron C; Goudemand J
Haemophilia; 2003 May; 9(3):303-8. PubMed ID: 12694522
[TBL] [Abstract][Full Text] [Related]
8. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications.
Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):577-88. PubMed ID: 16977568
[TBL] [Abstract][Full Text] [Related]
9. Causes, etiology and diagnosis of acquired von Willebrand disease: a prospective diagnostic workup to establish the most effective therapeutic strategies.
Sucker C; Michiels JJ; Zotz RB
Acta Haematol; 2009; 121(2-3):177-82. PubMed ID: 19506364
[TBL] [Abstract][Full Text] [Related]
10. Distinct mechanisms account for acquired von Willebrand syndrome in plasma cell dyscrasias.
Dicke C; Schneppenheim S; Holstein K; Spath B; Bokemeyer C; Dittmer R; Budde U; Langer F
Ann Hematol; 2016 May; 95(6):945-57. PubMed ID: 27040683
[TBL] [Abstract][Full Text] [Related]
11. Acquired von Willebrand syndrome--report of 10 cases and review of the literature.
Nitu-Whalley IC; Lee CA
Haemophilia; 1999 Sep; 5(5):318-26. PubMed ID: 10583513
[TBL] [Abstract][Full Text] [Related]
12. Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study.
Stuijver DJ; Piantanida E; van Zaane B; Galli L; Romualdi E; Tanda ML; Meijers JC; Büller HR; Gerdes VE; Squizzato A
Haemophilia; 2014 May; 20(3):326-32. PubMed ID: 24118466
[TBL] [Abstract][Full Text] [Related]
13. Reversal of acquired von Willebrand syndrome with allogeneic stem cell transplant for chronic lymphocytic leukemia.
Hegerova L; He F; Zantek ND; Vercellotti GM; Holtan SG; Reding MT
Blood Cells Mol Dis; 2019 Jul; 77():109-112. PubMed ID: 31029024
[TBL] [Abstract][Full Text] [Related]
14. Acquired von Willebrand disease caused by an autoantibody selectively inhibiting the binding of von Willebrand factor to collagen.
van Genderen PJ; Vink T; Michiels JJ; van 't Veer MB; Sixma JJ; van Vliet HH
Blood; 1994 Nov; 84(10):3378-84. PubMed ID: 7949092
[TBL] [Abstract][Full Text] [Related]
15. Acquired von Willebrand syndrome: an update.
Franchini M; Lippi G
Am J Hematol; 2007 May; 82(5):368-75. PubMed ID: 17133419
[TBL] [Abstract][Full Text] [Related]
16. Acquired von Willebrand's syndrome: a single institution experience.
Kumar S; Pruthi RK; Nichols WL
Am J Hematol; 2003 Apr; 72(4):243-7. PubMed ID: 12666134
[TBL] [Abstract][Full Text] [Related]
17. Establishing a method for in vitro investigation of mechanical parameters causing acquired von Willebrand syndrome in ventricular assist devices.
Egger C; Maas J; Hufen T; Schmitz-Rode T; Steinseifer U
Artif Organs; 2013 Sep; 37(9):833-9. PubMed ID: 23834027
[TBL] [Abstract][Full Text] [Related]
18. Acquired von Willebrand syndrome: features and management.
Mohri H
Am J Hematol; 2006 Aug; 81(8):616-23. PubMed ID: 16823821
[TBL] [Abstract][Full Text] [Related]
19. Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients.
Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Trummer G; Berchtold-Herz M; Schlensak C; Zieger B
Eur J Cardiothorac Surg; 2011 Dec; 40(6):1328-33; discussion 1233. PubMed ID: 21515067
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the Utility of von Willebrand Factor Propeptide in the Differential Diagnosis of von Willebrand Disease and Acquired von Willebrand Syndrome.
Stufano F; Boscarino M; Bucciarelli P; Baronciani L; Maino A; Cozzi G; Peyvandi F
Semin Thromb Hemost; 2019 Feb; 45(1):36-42. PubMed ID: 29913537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
